期刊文献+
共找到66篇文章
< 1 2 4 >
每页显示 20 50 100
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
1
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL uses Cosmetic Application
下载PDF
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
2
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
3
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
4
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
5
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL uses PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
6
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
7
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
8
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
9
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
10
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
阿莫西林克拉维酸钾颗粒联合替硝唑在小儿胃炎治疗中的效果 被引量:1
11
作者 郎具斌 《妇儿健康导刊》 2023年第7期108-109,119,共3页
目的探讨阿莫西林克拉维酸钾颗粒联合替硝唑在小儿胃炎治疗中的效果。方法选取2019年1月至2021年1月中核五〇四医院收治的110例小儿胃炎患儿,按照抽签法分为对比组与探析组,每组各55例。对比组采用阿莫西林克拉维酸钾颗粒治疗,探析组采... 目的探讨阿莫西林克拉维酸钾颗粒联合替硝唑在小儿胃炎治疗中的效果。方法选取2019年1月至2021年1月中核五〇四医院收治的110例小儿胃炎患儿,按照抽签法分为对比组与探析组,每组各55例。对比组采用阿莫西林克拉维酸钾颗粒治疗,探析组采用阿莫西林克拉维酸钾颗粒联合替硝唑治疗。比较两组临床疗效、不良反应总发生率、复发率及症状改善时间。结果探析组总有效率高于对比组,差异有统计学意义(P<0.05)。探析组不良反应总发生率及复发率均低于对比组,差异有统计学意义(P<0.05)。探析组症状改善时间均短于对比组,差异有统计学意义(P<0.05)。结论阿莫西林克拉维酸钾颗粒联合替硝唑治疗小儿胃炎,疗效较好,不良反应较少,且复发率低,值得临床推广应用。 展开更多
关键词 阿莫西林克拉维酸钾颗粒 替硝唑 小儿胃炎 治疗效果
下载PDF
The role of drug utilization evaluation in medical sciences
12
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
13
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
以奥美拉唑为主的三联疗法治疗小儿消化性溃疡60例 被引量:39
14
作者 吕茵 李治昌 《陕西医学杂志》 CAS 2013年第9期1125-1127,共3页
目的:探讨以奥美拉唑为主的三联疗法治疗小儿消化性溃疡的临床疗效。方法:选择120例消化性溃疡的患儿,按不同治疗方法分为观察组与对照组,每组60例。观察组采用奥美拉唑+阿莫西林+克拉霉素三联疗法,对照组采用雷尼替丁+阿莫西林+克拉霉... 目的:探讨以奥美拉唑为主的三联疗法治疗小儿消化性溃疡的临床疗效。方法:选择120例消化性溃疡的患儿,按不同治疗方法分为观察组与对照组,每组60例。观察组采用奥美拉唑+阿莫西林+克拉霉素三联疗法,对照组采用雷尼替丁+阿莫西林+克拉霉素三联疗法,比较两组患儿治疗1个月后的临床效果。结果:观察组患儿愈合率及总有效率分别达88.3%及98.3%,明显较对照组高(P<0.05)。观察组HP根除率为91.6%,明显较对照组(63.3%)高(P<0.05),而观察组复发率为3.3%,较对照组(8.3%)低(P<0.05)。两组患儿用药后不良反应无显著性差异(P>0.05)。结论:以奥美拉唑为主的三联疗法治疗小儿消化性溃疡安全有效,HP根除明显,治愈率高,复发率低,可作为小儿消化性溃疡的首选治疗方案。 展开更多
关键词 消化性溃疡 药物疗法 奥美拉唑 治疗应用 阿莫西林 治疗应用 雷尼替丁 治疗应用 对比研究 儿童
下载PDF
进口阿莫西林-舒巴坦治疗社区获得性肺炎的多中心随机对照研究 被引量:2
15
作者 李群 周新 +6 位作者 朱惠莉 张婕 李立 王永兴 黄文杰 许蒲生 李航 《世界临床药物》 CAS 2010年第9期538-542,共5页
目的评价进口阿莫西林-舒巴坦(特福猛)治疗轻、中度社区获得性肺炎(CAP)的有效性和安全性。方法采用随机多中心研究设计。受试组接受特福猛治疗,轻度患者剂量为1.5g/12h;中度患者剂量为3.0g/12h;对照组接受注射用头孢呋辛钠(西力欣)治疗... 目的评价进口阿莫西林-舒巴坦(特福猛)治疗轻、中度社区获得性肺炎(CAP)的有效性和安全性。方法采用随机多中心研究设计。受试组接受特福猛治疗,轻度患者剂量为1.5g/12h;中度患者剂量为3.0g/12h;对照组接受注射用头孢呋辛钠(西力欣)治疗,轻度患者剂量为1.5g/12h;中度患者剂量为1.5g/8h。各组均为静脉滴注,疗程7~14d。结果共327例患者入选,可进行疗效分析的病例共316例。受试组痊愈率和有效率分别为32.9%和88.2%,相应的对照组分别为33.5%和89.0%,两组相比差异无统计学意义(P>0.05)。受试组和对照组细菌清除率分别为85.2%和85.5%,两组相比差异无统计学意义(P>0.05)。两组药物相关不良反应发生率分别为6.06%和4.93%,组间差异无统计学意义(P>0.05)。结论进口阿莫西林-舒巴坦对轻、中度CAP临床疗效较好,使用安全,有较高的临床应用价值。 展开更多
关键词 阿莫西林-舒巴坦 头孢呋辛 社区获得性肺炎 治疗应用
下载PDF
养胃清幽汤对HP阳性消化性溃疡患者胃黏膜炎症及溃疡愈合作用的研究 被引量:20
16
作者 赵艳 姬锋养 《陕西中医》 2017年第2期154-156,共3页
目的:探讨幽门螺旋杆菌(HP)阳性消化性溃疡治疗中养胃清幽汤的应用价值。方法:92例HP阳性消化性溃疡患者随机分为对照组及治疗组,每组46例,对照组接受单纯西药治疗,治疗组接受西药联合养胃清幽汤治疗。分别对比两组临床症状、黏膜组织... 目的:探讨幽门螺旋杆菌(HP)阳性消化性溃疡治疗中养胃清幽汤的应用价值。方法:92例HP阳性消化性溃疡患者随机分为对照组及治疗组,每组46例,对照组接受单纯西药治疗,治疗组接受西药联合养胃清幽汤治疗。分别对比两组临床症状、黏膜组织炎症及溃疡愈合情况。结果:入组时两组间胃脘疼痛、胸胁胀满、嗳气吞酸、食少便溏、胃黏膜单核细胞浸润及中性粒细胞浸润评分比较无统计学差异,治疗3个月后,治疗组胃脘疼痛、胸胁胀满、嗳气吞酸、食少便溏、胃黏膜单核细胞浸润及中性粒细胞浸润评分均低于对照组(P<0.05)。同时,在3个月的治疗后,治疗组治疗总有效率高于对照组(P<0.05)。此外,两组药物不良反应发生率比较,未见统计学意义。结论:养胃清幽汤可有效的改善HP阳性的消化性溃疡患者黏膜炎症情况,并促进其愈合。 展开更多
关键词 消化性溃疡/中西医结合疗法 阿莫西林/治疗应用 @养胃清幽汤
下载PDF
不同质子泵抑制剂治疗Hp阳性消化性溃疡效果 被引量:6
17
作者 杨伟昂 彭颂兴 +1 位作者 曾小辉 张宏聪 《中国卫生标准管理》 2019年第15期92-94,共3页
目的探究Hp阳性消化性溃疡患者在进行治疗临床治疗过程中,选择不同质子泵抑制剂与克拉霉素、阿莫西林联合治疗的效果对比。方法本文对本院收治的76例患者进行分组对比研究,入选者均为Hp阳性消化性溃疡的患者,患者病例选择时间2016年6月-... 目的探究Hp阳性消化性溃疡患者在进行治疗临床治疗过程中,选择不同质子泵抑制剂与克拉霉素、阿莫西林联合治疗的效果对比。方法本文对本院收治的76例患者进行分组对比研究,入选者均为Hp阳性消化性溃疡的患者,患者病例选择时间2016年6月-2018年12月,设为38例对照组的患者治疗药物选择泮托拉唑、克拉霉素以及阿莫西林,设为38例观察组的患者治疗药物选择埃索美拉唑、克拉霉素以及阿莫西林。结果观察组消化性溃疡患者进行治疗后,总有效率92.10%,Hp根除率94.74%,腹痛缓解率为92.11%,对照组消化性溃疡患者进行治疗后,总有效率73.69%,Hp根除率78.95%,腹痛缓解率为71.05%,经统计对比可知P <0.05;观察组5.26%的患者出现不良反应,对照组13.15%的患者出现不良反应,经统计对比可知P> 0.05。结论 Hp阳性消化性溃疡患者在治疗过程中,医务人员采用如下药物实施治疗,即埃索美拉唑、克拉霉素以及阿莫西林,效果确切。 展开更多
关键词 HP阳性消化性溃疡 质子泵抑制剂 克拉霉素 阿莫西林 治疗效果 HP根除
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
18
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
Probiotic mixture VSL#3:An overview of basic and clinical studies in chronic diseases 被引量:11
19
作者 Fang-Shu Cheng Dan Pan +2 位作者 Bing Chang Min Jiang Li-Xuan Sang 《World Journal of Clinical Cases》 SCIE 2020年第8期1361-1384,共24页
Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted co... Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted considerable attention for its combined effect.VSL#3 is the only probiotic considered as a kind of medical food;it mainly participates in the regulation of the intestinal barrier function,including improving tight junction protein function,balancing intestinal microbial composition,regulating immune-related cytokine expression and so on.The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans(including children).We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies,including digestive systemic diseases(gastrointestinal diseases and hepatic diseases),obesity and diabetes,allergic diseases,nervous systemic diseases,atherosclerosis,bone diseases,and female reproductive systemic diseases. 展开更多
关键词 VSL#3 INTESTINAL barrier function CHRONIC DISEASES INTESTINAL MICROBIAL balance CYTOKINES therapeutic use
下载PDF
Medicinal plants with hepatoprotective activity in Iranian folk medicine 被引量:5
20
作者 Majid Asadi-Samani Najme Kafash-Farkhad +3 位作者 Nafiseh Azimi Ali Fasihi Ebrahim Alinia-Ahandani Mahmoud Rafieian-Kopaei 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第2期146-157,共12页
There are a number of medicinal combinations in the Iranian traditional medicine which are commonly used as tonic for liver.In this review,we have introduced some medicinal plants that are used mainly for the treatmen... There are a number of medicinal combinations in the Iranian traditional medicine which are commonly used as tonic for liver.In this review,we have introduced some medicinal plants that are used mainly for the treatment of liver disorders in Iranian folk medicine,with focus on their hepatoprotective effects particularly against CCI_4 agent.In this study,online databases including Web of Science.PubMed.Scopus,and Science Direct were searched for papers published from January 1970 to December 2013.Search terms consisted of medicinal plants,traditional medicine,folk medicine,hepatoprotective.Iran,liver,therapeutic uses,compounds,antioxidant.CCI_4.anti-inflammatory,and antihepatotoxic,hepatitis,alone or in combination.Allium hirtifolium Boiss..Apium graveolens L..Cynara scolyinus.Berberis vulgaris L..,Calendula officinalis,Nigella sativa L..Taraxacum officinale.Tragopogon porrifolius.Prangos ferulacea L..Allium sativum,Marribium vulgare,Ammi majus L..Citrullus lanatus Thunb.Agrimonia eupatoria L.and Primus armeniaca L.are some of the medicinal plants that have been used for the treatment of liver disorders in Iranian folk medicine.Out of several leads obtained from plants containing potential hepatoprotective agents,silymarin,P-sitosterol,betalain,neoandrographolide.phyllanthin.andrographolide.curcumin.picroside.hypophyllanlhin.kutkoside,and glycyrrhizin have been demonstrated to have potent hepatoprotective properties.Despite encouraging data on possibility of new discoveries in the near future,the evidence on treating viral hepatitis or other chronic liver diseases by herbal medications is not adequate. 展开更多
关键词 Medicinal plants Iran COMPOUNDS LIVER therapeutic uses CCl_4
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部